To qualify for this annual report, agencies must have the capabilities to develop marketing strategies that target healthcare professionals (physicians, nurse practitioners, nurses, pharmacists, etc.), and/or consumers, and/or patients, and/or stakeholders such as managed market payors.
Tag Archive for: featured
A listing of holding companies/networks & their healthcare communications agencies, and independent healthcare communications agencies.
For the tenth year, Med Ad News chose new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.
Marketers continue to leverage the power of mobile devices, but have learned it’s not all about the apps.
Point of care interactions between patients and healthcare professionals are undergoing significant changes. Whether in the doctor’s office, hospital or pharmacy, new care models are being established that are designed to bring fundamental change to the doctor-patient relationship.
The Coalition for Healthcare Communication (Coalition) has faced multiple challenges in Washington over the years, including major tax legislation (more on that below), and now its Executive Committee has adopted a new mission statement designed to both combat information quackery and its more modern rendition – fake medical news – and to highlight and raise the ethical standards of the medical communication industry.
GSW, an INC Research/inVentiv Health company and industry leader in healthcare advertising, named Sonja Foster-Storch as president. Foster-Storch reports to Lisa Stockman, president of inVentiv Health Communications.
Two Omnicom Health Group agencies will have new leadership as of January 1, 2018. Mario Muredda was named CEO of Harrison and Star, and Kristin Kantak will be CEO of Biolumina.
The Inception Companies appointed Matt Giegerich, longtime CEO of WPP’s Ogilvy CommonHealth, to serve as CEO for Inception’s two largest business units.
Whatever comes out of Congress on the “repeal and replace” of the Affordable Care Act (ACA or Obamacare) matters because it will affect the bottom line of the life sciences industry as well as all of its industry partners.
